Cargando…

Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis

Cryptococcus neoformans is an opportunistic fungal pathogen and the causative agent of the disease cryptococcosis. Cryptococcosis is initiated as a pulmonary infection and in conditions of immune deficiency disseminates to the blood stream and central nervous system, resulting in life-threatening me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mor, Visesato, Farnoud, Amir M., Singh, Ashutosh, Rella, Antonella, Tanno, Hiromasa, Ishii, Keiko, Kawakami, Kazuyoshi, Sato, Toshiya, Del Poeta, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833283/ https://www.ncbi.nlm.nih.gov/pubmed/27082428 http://dx.doi.org/10.1371/journal.pone.0153853

Ejemplares similares

Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development
por: Rella, Antonella, et al.
Publicado: (2015)

Transmembrane transporter expression regulated by the glucosylceramide pathway in Cryptococcus neoformans
por: Singh, Arpita, et al.
Publicado: (2015)

Synthesis and Biological Properties of Fungal Glucosylceramide
por: Del Poeta, Maurizio, et al.
Publicado: (2014)

Correction: Synthesis and Biological Properties of Fungal Glucosylceramide
por: Del Poeta, Maurizio, et al.
Publicado: (2015)

Hydroxyurea treatment inhibits proliferation of Cryptococcus neoformans in mice
por: Tripathi, Kaushlendra, et al.
Publicado: (2012)

Surface Localization of Glucosylceramide during Cryptococcus neoformans Infection Allows Targeting as a Potential Antifungal
por: Rhome, Ryan, et al.
Publicado: (2011)

Administration of Glucosylceramide Ameliorated the Memory Impairment in Aged Mice
por: Lee, Yeonju, et al.
Publicado: (2013)

Cryptococcus neoformans Δsgl1 Vaccination Requires Either CD4(+) or CD8(+) T Cells for Complete Host Protection
por: Normile, Tyler G., et al.
Publicado: (2021)

Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1
por: Normile, Tyler G., et al.
Publicado: (2022)

Topical Administration of Heat-Killed Enterococcus faecalis Strain KH2 Promotes Re-Epithelialization and Granulation Tissue Formation during Skin Wound-Healing
por: Tanno, Hiromasa, et al.
Publicado: (2021)

Cutaneous wound healing promoted by topical administration of heat-killed Lactobacillus plantarum KB131 and possible contribution of CARD9-mediated signaling
por: Ishi, Shinyo, et al.
Publicado: (2023)

Ubiquitous Transgene Expression of the Glucosylceramide-Synthesizing Enzyme Accelerates Glucosylceramide Accumulation and Storage Cells in a Gaucher Disease Mouse Model
por: Barnes, Sonya, et al.
Publicado: (2014)

Defining the glucosylceramide population of C. elegans
por: Xatse, Mark A., et al.
Publicado: (2023)

Ceramides and glucosylceramides are independent antagonists of insulin action
por: Chavez, Jose A, et al.
Publicado: (2012)

Cryptococcus neoformans Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model
por: Colombo, Ana Caroline, et al.
Publicado: (2019)

Recovery Effects of Oral Administration of Glucosylceramide and Beet Extract on Skin Barrier Destruction by UVB in Hairless Mice
por: Tokudome, Yoshihiro, et al.
Publicado: (2017)

Cryptococcosis
por: Haley, Lenore D.
Publicado: (1957)

Cryptococcosis
por: Maziarz, Eileen K., et al.
Publicado: (2014)

Cryptococcosis
por: Forrestel, Amy K.
Publicado: (2018)

Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions
Publicado: (1992)

Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis
por: Halter, David, et al.
Publicado: (2007)

Glucosylceramide synthase maintains influenza virus entry and infection
por: Drews, Kelly, et al.
Publicado: (2020)

Contribution of Invariant Natural Killer T Cells to the Clearance of Pseudomonas aeruginosa from Skin Wounds
por: Tanno, Hiromasa, et al.
Publicado: (2021)

Oral Administration of Glucosylceramide Suppresses Tumor Growth by Affecting the Ceramide/Sphingosine-1-Phosphate Balance in Breast Cancer Tissue
por: Moro, Kazuki, et al.
Publicado: (2023)

Cryptococcosis and Cryptococcus
por: Francisco, Elaine Cristina, et al.
Publicado: (2021)

Pulmonary Cryptococcosis
por: Howard-Jones, Annaleise R., et al.
Publicado: (2022)

A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease
por: Fujii, Takahiro, et al.
Publicado: (2021)

ARF6 Regulates Neuron Differentiation through Glucosylceramide Synthase
por: Li, Lu, et al.
Publicado: (2013)

New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression
por: Gupta, Vineet, et al.
Publicado: (2013)

Effects of Peach (Prunus persica)-Derived Glucosylceramide on the Human Skin
por: Koikeda, Takashi, et al.
Publicado: (2017)

Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases
por: Deguchi, Hiroshi, et al.
Publicado: (2017)

Glucosylceramide acyl chain length is sensed by the glycolipid transfer protein
por: Backman, Anders P. E., et al.
Publicado: (2018)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
por: Popovic, Zoran V., et al.
Publicado: (2017)

Inhibitory Effects of Glucosylceramide on Tumorigenesis Induced by a Carcinogen in Mice
por: Fujiwara, Kazunori, et al.
Publicado: (2019)

Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease
por: Reza, Safoura, et al.
Publicado: (2021)

Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels
por: te Vruchte, Danielle, et al.
Publicado: (2022)

Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids
por: Mor, Visesato, et al.
Publicado: (2015)

Erratum for Mor et al., “Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids”
por: Mor, Visesato, et al.
Publicado: (2018)

Sphingolipidomics: An Important Mechanistic Tool for Studying Fungal Pathogens
por: Singh, Ashutosh, et al.
Publicado: (2016)

Massive mediastinal cryptococcosis in a young immunocompetent patient
por: Okachi, Shotaro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_84jl9cslbhqeqpsf1srcc3hc85